This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Sep;159(16):40.

doi: 10.1007/s15006-017-0062-z.

Haben wir Ärzte Angst vor Statinen?

[Article in German]

J Zeeh¹

Affiliations

PMID: 28952088
DOI: 10.1007/s15006-017-0062-z

Comment

Haben wir Ärzte Angst vor Statinen?

[Article in German]

J Zeeh. MMW Fortschr Med. 2017 Sep.

. 2017 Sep;159(16):40.

doi: 10.1007/s15006-017-0062-z.

Author

J Zeeh¹

Affiliation

¹ .

PMID: 28952088
DOI: 10.1007/s15006-017-0062-z

No abstract available

PubMed Disclaimer

Comment on

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.
Gupta A, Thompson D, Whitehouse A, Collier T, Dahlof B, Poulter N, Collins R, Sever P; ASCOT Investigators. Gupta A, et al. Lancet. 2017 Jun 24;389(10088):2473-2481. doi: 10.1016/S0140-6736(17)31075-9. Epub 2017 May 2. Lancet. 2017. PMID: 28476288 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information